BTK inhibitors

Ibr 70 mg Pill - yellow capsule-shape, 18mm

Generic Name: ibrutinib

Pill with imprint ibr 70 mg is Yellow, Capsule-shape and has been identified as Imbruvica 70 mg. It is supplied by Pharmacyclics, Inc.

Imbruvica is used in the treatment of Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma; Waldenström Macroglobulinemia; Lymphoma; Mantle Cell Lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 70 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Imbruvica (Ibrutinib)-ibr 70 mg-70 mg-Yellow-Capsule-shape

Imbruvica
Generic Name: ibrutinib
Imprint: ibr 70 mg
Strength: 70 mg
Color: Yellow
Size: 18.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: BTK inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 57962-0070
Inactive Ingredients:
Latest News
Related Drugs